Clinical Trials Browser

OTHER × Meropenem × 90 days × Clear all

NCT07590648 2026-05-15

E-STOP2

Phase 4 Not yet recruiting

Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

NCT04983901 2026-04-06

PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN

Phase 2 Completed

100 enrolled 38 charts

Other hematologic neoplasm

Hematologic Neoplasms